Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1

INTRODUCTION: Glucagon-like peptide (GLP)-1 receptor agonists are glucose-lowering agents associated with weight loss, cardiovascular benefits, and low hypoglycemic risk and are recommended by recent guidelines as first-line therapy for some patients with type 2 diabetes (T2D). This post hoc analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi Ming, Zhang, Li Hui, Li, Xue Jun, Zhang, Bin, Hou, Jia Ning, Tong, Nan Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192982/
https://www.ncbi.nlm.nih.gov/pubmed/32219675
http://dx.doi.org/10.1007/s13300-020-00799-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192982/
https://www.ncbi.nlm.nih.gov/pubmed/32219675
http://dx.doi.org/10.1007/s13300-020-00799-w

Ejemplares similares